MEMBER | 2015 Annual Scientific Meeting (Non-CME)


HFSA’s Annual Scientific Meeting is planned by and for cardiologists, nurses, pharmacists, and scientists, with something of interest to everyone on the heart failure team. The 2015 program includes significant content in advanced heart failure, pharmacology, patient care, diagnosis and management, devices and technology, and bench-to-bedside translational science. Educational content is designed to meet the range of needs from those new to heart failure to the well-established specialists.

Standard: $350.00

Products

Clinical Fundamentals I: The Immune Response in Cardiovascular Disease

Preview Available

Clinical Fundamentals I: The Immune Response in Cardiovascular Disease


Describe the role of the immune response in cardiovascular disease, including heart failure.

Speaker Objective(s):

  • The Nuts and Bolts of Basic Immunology
  • Inflammation as a Pathophysiologic Mechanism in Heart Failure
  • The Role of the Immune Response in Myocarditis
  • The Immunology of Cardiac Allograft Rejection
  • Targeting Inflammation in the Development of Cardiovascular Disease

Moderator(s): Speaker(s):

Transitions in Heart Failure Care: It's Not Just About Hospital to Home

Preview Available

Transitions in Heart Failure Care: It's Not Just About Hospital to Home


Manage transitions in heart failure care with effective programs and attention to patient needs.

Speaker Objective(s):

  • Post-Hospital Care Programs: Gems or Stones
  • Coordinators versus Checklists to Achieve Clinical Outcomes
  • Common Patient Issues Affecting Transition Care
  • Transitioning to End-of-Life

Moderator(s): Speaker(s):
  • Nancy Albert, PhD, CCNS, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN, Cleveland Clinic
  • Robb Kociol, MD, Director, Advanced Heart Failure and MCS, Beth Israel Deaconess Medical Center
  • Mary Norine Walsh, MD, St Vincent Heart Center
  • Ann Laramee, NP, MS, FHFSA, MS, ANP-BC, ACNS-BC, CHFN, ACHPN, Cardiology Nurse Practitioner and Clinical Nurse Specialist, Palliative Care Medicine, University of Vermont Medical Center

Hemodynamics in Heart Failure (Joint Session with SCAI)

Preview Available

Hemodynamics in Heart Failure (Joint Session with SCAI)


Identify the role of hemodynamics in heart failure assessment and management.

Speaker Objective(s):

  • Basics of Hemodynamics in the Cath lab
  • Hemodynamics Assessment Pre-VAD/Transplant
  • The Hemodynamics of HFpEF
  • The Hemodynamics of MCS
  • The Hemodynamics of MCS
  • TVAR and MitraClip Hemodynamics

Moderator(s): Speaker(s):
  • Nitasha Sarswat, MD, Univeristy of Chicago Medicine
  • Olcay Aksoy, MD
  • Nir Uriel, MD, MSc, Louis Block Professor of Medicine; Director, Heart Failure, Transplant and Mechanical Circulatory Support, University of Chicago
  • Mark Drazner, MD, FHFSA, University of Texas Southwestern
  • James C. Fang, MD, FHFSA, Professor of Medicine; Chief, Division of Cardiovascular Medicine; Executive Director, Cardiovascular Service Line, University of Utah

Ask the Experts: Challenging Clinical Situations in MCS

Preview Available

Ask the Experts: Challenging Clinical Situations in MCS


Identify critical issues and clinically sound responses in the management of challenging MCS patients.

Speaker Objective(s):

  • LVAD in Restrictive Cardiomyopathy
  • LVAD in Chemotherapy-Induced Cardiomyopathy
  • LVAD in Children
  • LVAD in Women
  • LVAD in Morbidly Obese Patients

Moderator(s): Speaker(s):

Recent Advances in the Management of Myocarditis (Joint Session)

Preview Available

Recent Advances in the Management of Myocarditis (Joint Session)


Describe recent advances in myocarditis diagnosis, prognosis, and management.

Speaker Objective(s):

  • Recent Translational Studies in Cardiovascular Inflammation
  • Epidemiology, Mechanisms and Prevention of Sudden Death in Myocarditis
  • Techniques to Improve the Diagnosis Value of Endomyocardial Biopsy
  • Cardiac MRI for Diagnosis and Prognosis in Suspected Myocarditis

Moderator(s): Speaker(s):

The Prevention of Heart Failure: Targets and Strategies (Joint Session AHA)

Preview Available

The Prevention of Heart Failure: Targets and Strategies (Joint Session AHA)


Outline strategies for the prevention of heart failure, identifying pros and cons.

Speaker Objective(s):

  • Salt control in the Population to Prevent HF (Pro)
  • Salt control in the Population to Prevent HF (Con)
  • Discussion: Salt, HTN, and the Prevention Heart Failure Discussion
  • Discussion: Salt, HTN, and the Prevention Heart Failure Discussion
  • DD: Can it be Stopped from Causing HFpEF
  • Biomarkers for Prediction and Prevention of Heart Failure – Beyond BNP
  • Nurse-Practitioner-Based-Community Outreach to Control Lifestyle Issues Leading to Heart Failure
  • HTN Rx for Prevention of HF
  • Discussion: Salt, HTN, and the Prevention Heart Failure Discussion

Moderator(s):
  • Biykem Bozkurt, MD, PhD, FACC, FAHA, Associate Director, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX
  • Mariell Jessup, MD, AHA/LeDucq
Speaker(s):
  • Scott Hummel, MD, MS, University of Michigan / Ann Arbor VA Health System
  • Javed Butler, MD, MPH, FHFSA, Professor and Chairman of the Department of Medicine, University of Mississippi Medical Center
  • Margaret Redfield, MD, Mayo Clinic
  • Jennifer Ho, MD, Boston Medical Research Center
  • Connie Lewis, MSN, ACNP-BC, Vanderbilt University

Tool Kit for the Evaluation and Selection of the Patient for MCS (ICCAC-VAD Joint Session)

Preview Available

Tool Kit for the Evaluation and Selection of the Patient for MCS (ICCAC-VAD Joint Session)


Use effective strategies for the selec-tion of patients for mechanical circulatory support.

Speaker Objective(s):

  • New Metrics for Assessing the Progression of Heart Failure: More than VO2!
  • Who Does Poorly with MCS? INTERMACS and Beyond
  • Evaluating Psychosocial Risk: Is an Identified Caregiver Enough?
  • MCS as a Means to Evaluation Adherence: Expensive Test or Justifiable Alternative?
  • Have We Agreed how to Assess the Right Ventricle
  • What Do We Know About Moving from ECMO to VAD?
  • My Single Biggest Mistake on Selection
  • My Single Biggest Mistake on Selection

Moderator(s): Speaker(s):
  • Robb Kociol, MD, Director, Advanced Heart Failure and MCS, Beth Israel Deaconess Medical Center
  • Lynne Warner Stevenson, MD, Director of Cardiomyopathy, Lisa M Jacobson Professor of MedicineProfessor and Director of Cardiomyopathy & Program Director, Advanced Heart Failure Fellowship Program, Vanderbilt University
  • Lori Anderson, RN
  • Jeffrey Teuteberg, MD, Stanford University
  • Pavan Atluri, MD, Assistant Professor of Surgery, University of Pennsylvania Division of Cardiovascular Surgery
  • Francis Pagani, MD, PhD, University of Michigan

Excellence in Translational Science: Bench to Bedside

Preview Available

Excellence in Translational Science: Bench to Bedside


Describe new findings in translational science and their implications for heart failure treatment.

Speaker Objective(s):

  • Cellular and Molecular Mechanisms (sGC/pGC/cGMP/PKG)
  • Soluble Guanylyl Cyclase: From Biology to Drug Discovery
  • Particulate Guanylyl Cyclase: From Biology to Drug Discovery
  • What Genetics Have Told Us About sGC and pGC pathways in CV Disease
  • sGC Therapeutics for Heart Failure and Pulmonary Hypertension
  • Natriuretic Peptides for Acute and Chronic Heart Failure
  • Natriuretic Peptides for Acute and Chronic Heart Failure
  • A New Paradigm in cGMP Therapeutics: ARNI’s, PARADIGN and Beyond

Moderator(s): Speaker(s):

Disposition Decision Making From the ER (Joint Session SAEM)

Preview Available

Disposition Decision Making From the ER (Joint Session SAEM)


Identify critical factors in effective heart failure disposition decisions in the ER.

Speaker Objective(s):

  • Hospital Admission – The Path of Least Resistance
  • Identifying Low-Risk and Impediments to Safe Discharge
  • What Happens in an Observation Unit?
  • Optimizing Post‐Discharge Care‐ ED and OU Transitions
  • ED vs. Hospital Discharge ‐ Should Endpoints be the Same?

Moderator(s): Speaker(s):

Rapid Fire Abstracts I

Preview Available

Rapid Fire Abstracts I


Discuss findings from recent research in HF and their implications for research and clinical practice.


Moderator(s):
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content